CBD may reduce anxiety in one tightly controlled situation, but there is not yet enough evidence to recommend it as a treatment. In a 2011 trial of 24 people with untreated social anxiety disorder, a single 600 mg dose of CBD reduced the anxiety caused by a simulated public speaking test, [bergamaschi-2011] while a 2020 systematic review of medicinal cannabis in psychiatry called it premature to recommend cannabinoid-based interventions. [sarris-2020] This guide covers what those studies found, what they could not show and what to ask a doctor. Our overview of anxiety covers the condition itself, and our guide to natural remedies for anxiety covers other things people try.
Does CBD help anxiety?
It may help in some situations, but the evidence is too thin to recommend it. CBD (cannabidiol) is one major compound from the cannabis plant that is described as non-psychotomimetic, meaning it does not mimic psychosis, and it has shown anxiety-reducing effects in humans and animals. [bergamaschi-2011] The strongest human evidence we could verify is one small trial in social anxiety disorder, and the wider review rates the whole field as at an early stage. [sarris-2020]
What did the social anxiety trial find?
It found less anxiety during a simulated speech after one dose. The 2011 study gave 24 people with untreated social anxiety disorder either 600 mg of CBD (12 people) or placebo (12 people), randomly assigned and double-blind, an hour and a half before a simulated public speaking test. Twelve healthy volunteers did the same test with no medication. People rated their mood and their negative self-statements, and blood pressure, heart rate and skin conductance were measured at six points during the test. [bergamaschi-2011]
Pretreatment with CBD significantly reduced anxiety, cognitive impairment and discomfort in speech performance, and reduced alertness during the anticipation of the speech. The placebo group rated anxiety, impairment, discomfort and alertness higher than the healthy group, and their negative self-statements rose during the test, an increase that was almost abolished with CBD. People who took CBD did not differ significantly from the healthy volunteers on negative self-statements or on cognitive impairment, discomfort and alertness. [bergamaschi-2011]
The authors called it a preliminary study. The abstract gives results for the self-rated measures and does not report the physiological ones, so we cannot say whether heart rate or blood pressure changed. [bergamaschi-2011]
What does the wider evidence say?
It says the field is at an early stage. The 2020 review was the first clinically focused systematic review of medicinal cannabis across the major psychiatric disorders, and it concluded that the evidence is nascent and that it is currently premature to recommend cannabinoid-based interventions. Isolated positive studies gave tentative support for CBD for reducing social anxiety. [sarris-2020]
For sleep and post-traumatic stress disorder, it found case studies suggesting possible benefit, but described the evidence as weak. It found no benefit for depression from high-THC products or for CBD in mania, and it advised caution with high-THC formulations, avoiding them in youth and in people with anxiety or psychotic disorders. [sarris-2020] That matters for anyone with anxiety, because a product with THC in it is a different thing from CBD alone.
What about the quality of CBD products?
The only product-quality data we could verify concerns a narrow case. A 2023 JAMA test of 25 melatonin gummies included five that declared CBD, and the measured CBD was 104% to 118% of the labelled amount, so those labels were close. The same letter notes that CBD is approved by the US Food and Drug Administration to treat refractory seizures caused by three rare genetic disorders, not anxiety. [cohen-2023-cbd] One product with no detectable melatonin contained 31.3 mg of CBD, which shows that what is inside a supplement is not always what the front of the pack suggests. [cohen-2023-cbd]
| Question | What the studies found | Caveat |
|---|---|---|
| Less anxiety in a speech? | Significantly reduced after one 600 mg dose (24 people) | Preliminary, one session |
| Same as healthy volunteers? | No significant differences on several ratings | Self-rated measures only reported |
| Ready to recommend? | No: premature (2020 review of medicinal cannabis) | Evidence described as nascent |
| Sleep or PTSD? | Case studies suggest possible benefit | Weak evidence |
| Product quality? | CBD 104% to 118% of label in five gummies | Tiny sample, one product type |
Questions worth taking to a doctor
Tick anything that applies. This is a preparation prompt for a conversation about CBD, it cannot diagnose anything and it does not say whether CBD is right for you.
0 of 6 ticked
Several of these affect whether CBD or any cannabis product is sensible. Bring the list to your appointment.
Enough here to be worth describing to a doctor, including what else you take and what is in any product.
None of these stands out as a reason to raise CBD first. If anxiety is still a problem, a conversation with a doctor is a good start.
The screener is a short self-check based on the GAD-7, not a diagnosis, and neither it nor this list tells you whether to take CBD.
What can this research not show?
It cannot show whether CBD will help your anxiety, at what dose or for how long. Five limits matter most:
- It is one small trial. Twelve people took CBD, in one session, and the authors called it preliminary. [bergamaschi-2011]
- It tested a single dose in a simulated situation. A 600 mg dose taken once before a laboratory speaking test says nothing about taking CBD daily or in everyday life. [bergamaschi-2011]
- It covers social anxiety disorder in untreated people. Results may differ in other kinds of anxiety, or in people already on treatment. [bergamaschi-2011]
- The wider review calls the field early. It judged it premature to recommend cannabinoid-based treatments. [sarris-2020]
- Product quality is mostly unstudied here. The only data we could verify are five CBD-containing gummies. [cohen-2023-cbd]
What should you ask a doctor?
Ask whether CBD is sensible with any medicines you take, what is known about the specific product, whether a treatment with stronger evidence should come first, and what to do if it does not help. This section is our suggestion and is not something the studies tested.
Our guides to anxiety medication, CBT for social anxiety and fear of public speaking cover other routes. If you want a rough picture of your anxiety before an appointment, our anxiety screener, built on the GAD-7, is a short self-check. It measures generalised anxiety, so read it as a general signal, and it is not a diagnosis.
When to seek help
Speak to a doctor if anxiety has lasted several weeks, is getting in the way of work, relationships or sleep, or if you are thinking about taking CBD alongside other medicines. If you feel unable to stay safe, contact your local emergency services or a crisis helpline.
How MyFreud can help
A record shows a doctor what has and has not helped. Daily mood tracking in MyFreud shows how your days run over weeks, and the notepad is somewhere to note what you took, when anxiety peaked and what happened. It does not replace a doctor.
Download MyFreud and start today: App Store or Google Play.